Anorexia

The relationship between obesity and disordered eating behaviors represents a complex combination of psychological, physiological and environmental influences.

NEW YORK — Referrals for eating disorder treatment spiked during the COVID-19 pandemic, with patients more likely to present with eating disorder as a primary diagnosis, according to a poster at the American Psychiatric Association annual meeting.

Anorexia nervosa during pregnancy was associated with several adverse neonatal outcomes, such as preterm and small for gestational age birth, compared with women without eating disorders, researchers reported.

Primary care providers are on the front lines of diagnosing and treating anorexia nervosa — a particularly complex eating disorder, according to experts.

Low-dose olanzapine significantly improved appetite and weight gain among patients with newly diagnosed cancer undergoing chemotherapy, according to study results published in Journal of Clinical Oncology.

Among girls and women with anorexia nervosa, endogenous ghrelin was associated with weight gain, according to findings published in JAMA Network Open.

This year, Eating Disorders Awareness Week is being recognized from Feb. 27 to March 5.

The American Psychiatric Association plans to align treatment of eating disorders with a focus on risk-benefit analysis of physical and psychosocial factors, according to new guidelines published in the American Journal of Psychiatry.

COMPASS Pathways PLC has announced the launch of a multi-center, double-blind randomized controlled phase 2 clinical trial investigating the efficacy of COMP360 psilocybin, along with psychological support, in those with anorexia nervosa.

Children, adolescents and older adults were underrepresented in U.S. clinical trials investigating eating disorders, despite federal guidance urging increased participation of individuals of all ages, according to researchers.